资源描述：
《莫沙必利治疗114例胃食管反流病临床观察》由会员上传分享，免费在线阅读，更多相关内容在工程资料-天天文库。
1、莫沙必利治疗114例胃食管反流病临床观察作者：赵忠岩1,李路平2,于倩2单位：1.吉林大学中日联谊医院急救医学科，吉林长春1300312吉林大学中日联谊医院药剂科，吉林长春130031【摘要】目的：评价莫沙必利治疗胃食管反流病(GERD)的作用及安全性。方法：采用随机对照临床研究的方法，将诊断为GERD的114例患者随机分为3组，奥美拉呻+莫沙必利组36例,奥美拉哇+吗丁咻组38例，单纯奥美拉哇组40例,疗程为4周。结果：治疗2周吋白觉症状的缓解率在3组Z间差异无统计学意义，但奥美拉呻+莫沙必利组治疗4周吋的症状缓解率明显优于单纯奥美拉醴组(P<0
2、.05),而且在停跖2周后症状的复发率也明显低于单纯奥美拉哇组(P<0.05),但与奥美啦岬+吗丁I林组比较差异无统计学意义。治疗4周后监测食管下段24hpH值，结果表明，接受奥美拉啤+莫沙必利治疗者pH值<4时间百分比(pH值<4时间％)和持续≥5min的反流次数比奥美拉哇+吗丁嚇纟I［和单纯奥美拉I坐纽.明显减少(P<0.05),但pH值<4的反流次数及下食管括约肌压力(LESP)在3组间差异无统计学意义。结论：口服莫沙必利可以明显减少食管下段pH值<4时
3、'可％及长时间反流次数，并可有效的缓解GERD的症状
4、，且复发率较单纯应用奥美拉咙治疗明显降低。【关键词】莫沙必利;胃食管反流病;奥美拉II坐ClinicalobservationofMosaprideinthetreatmentofgastroesophagealrefluxdisease：Areportof114casesZHAOZhong-yanl,LILu-ping2,YUQian2(1.DepartmentofEmergency,China-JapanUnitedHospital,JilinUnivercity,Changchun130031,China;2.DepartmentofPharmac
5、y,China-JapanUnitedHospital,JilinUnivercity,Changchun130031,China)Abstract：ObjectiveToevaluatetheutilityandsafetyofMosaprideincuringgastroesophagealrefluxdisease(GERD).MethodAccordingtotheclinicalstudymethodofrandomcomparison,114patientsweredepartedintothreegroupsatrandom(36forOm
6、eprazoleandMosapride,38forOmeprazoleandDomperidoneand40foronlyOmeprazole).Thecourseoftreatmentlastedfourweeks.ResultsAftertwoweeks1treating,therewasnosignificantdifferenceintheremissionrateoftherationalsymptomofthethree.Butafterfourweeks,theremissionrateofthegroupusingOmeprazolea
7、ndMosapridewasobviouslyhigherthanthatusingOmeprazolesimplyandtherecurrencerateaftertwoweeks1discontinuationwasobviouslylowerthanthat,butithadnosignificantdifferencefromthegroupusingOmeprazoleandDomperidone.Monitoring24hpHafterfourweeks1therapy,theresultsshowedthatthetimepercentag
8、eofpH&l(;4andtherefluxtimeslastingmorethan5minutesofthepatientsusingOmeprazoleandMosapridewereobviouslylowerthantheothertwogroups.ButtherewasnosignificantdifferenceoftherefluxtimesofpH<4andloweresophagealsphincterpressure(LESP)inthethreegroups.ConclusionMosaprideinadoseof30mg/
9、dcausesasignificantdecreaseinthepercenta
